Abstract
Introduction
Angiotensin-converting enzyme inhibitors (ACEIs) are reported to reduce the incidence of aspiration pneumonia in hypertensive patients. In this study, a metaanalysis was conducted to obtain statistically more reliable estimates of outcome.
Methods
The MEDLINE and JMEDICINE databases were searched and the following study selection criteria were applied: (1) comparative controlled studies identified with the following keywords: drug therapy, ACEI, hypertension, swallowing function, dysphagia, stroke, and pneumonia; (2) a minimum follow-up period of 6 months; and (3) a minimum number of patients of more than 100. Patients with hypertension and a history of stroke or transient ischemic attack (TIA) in five controlled studies that reported the incidence of pneumonia were included in the analysis.
Results
A total of 8,693 post-stroke patients were given ACEIs with another antihypertensive agent or placebo as a control. In all studies, ACEIs, particularly imidapril, exhibited preventive effects equating to a relative risk that ranged from 0.32 to 0.81 compared with controls. In the combined studies the overall relative risk of ACEI-treated patients versus controls was 0.61 (95% confidence intervals [CI] 0.51–0.75; P < 0.001). Among Asian patients, the relative risk was 0.42 (95% CI 0.32–0.56; P < 0.001). Among Japanese patients, an even greater preventive effect was found for ACEIs versus other antihypertensives (relative risk: 0.38 [95% CI 0.27-0.54; P < 0.001]).
Conclusion
ACEIs appear to be more effective than other antihypertensive agents or placebo in reducing pneumonia risk in post-stroke patients, especially in Asian populations.
Similar content being viewed by others
References
Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665–671.
Pellegrini CA, DeMeester TR, Johnson LF, Skinner DB. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality and results of surgical therapy. Surgery. 1979;86:110–119.
Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003;51:1018–1022.
Doggett DL, Tappe KA, Mitchell MD, Chapell R, Coates V, Turkelson CM. Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature. Dysphagia. 2001;16:279–295.
Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625.
Kimura K, Minematsu K, Kazui S, Yamaguchi T; the Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC). Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis. 2005;19:171–178.
Nakagawa T, Wada H, Sekizawa K, Arai H, Sasaki H. Amantadine and pneumonia. Lancet. 1999;353:1157.
Yamaya M, Yanai M, Ohrui T, Arai H, Sekizawa K, Sasaki H. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc. 2001;49:687–688.
Shinohara Y; the CSPS Group. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis. 2006;22:57–60.
Arai T, Yoshimi N, Fujiwara H, Fujiwara H, Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology. 2003;61:1625–1626.
Sekizawa K, Matsui T, Nakagawa T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998;352:1069.
Ohkubo T, Chapman N, Neal B, et al; the Perindopril Protection Against Recurrent Stroke Study Collaborative Group. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004;169:1041–1045.
Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet. 1998;352:1937–1938.
Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9:1187–1200.
Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens. 2000;13:1050–1051.
Arai T, Yasuda Y, Takaya T, et al. Angiotensinconverting enzyme inhibitor, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke. Chest. 2001;119:660–661.
Akutagawa O, Honda K, Sasaki T. A study of prevention of pneumonia development in the elderly by ACE inhibitors. Progr Med. 2002;22:2705–2708. In Japanese.
Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology. 2005;64:573–574.
Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials. 2001;22:102–110.
Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke. 1996;27:415–420.
Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Identification and management of dysphagia. A national clinical guideline. Edinburgh: Elliott House; 2010.
MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: Observational studies. Lancet. 2001;357:455–462.
Van de Garde EMW, Souverein PC, Hak E, Deneer VH, van den Bosch JM, Leufkens HG. Angiotensinconverting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. 2007;25:235–239.
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: A review of the literature and pathophysiology. Ann Intern Med. 1992;117:234–242.
Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113:1425.
Itoh M, Meguro K, Fujiwara T, et al. Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET. Ann Nucl Med. 1994;8:245–251.
Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc. 2001;49:85–90.
Nakagawa T, Ohrui T, Sekizawa K, Sasaki H. Sputum substance P in aspiration pneumonia. Lancet. 1995;345:1447.
Cascieri MA, Bull HG, Mumford RA, Patchett AA, Thornberry NA, Liang T. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol. 1984;25:287–293.
Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis. 1988;137:331–336.
Sekizawa K, Jia YX, Ebihara T, Hirose Y, Hirayama Y, Sasaki H. Role of substance P in cough. Pulm Pharmacol. 1996;9:323–328.
Medhora M, Gao F, Jacobs ER, Moulder JE. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 2012;17:66–71.
Woo J, Chan TYK. A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract. 1991;45:178–180.
Chan WK, Chan TYK, Luk WK, Leung VK, Li TH, Critchley JA. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol. 1993;44:299–300.
Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40:141–144.
Sharpe N; the international HOPE TIPS investigators. The HOPE TIPS: the HOPE study translated into practices. Cardiovasc Drugs Ther. 2005;19:197–201.
Morimoto S, Okaishi K, Onishi M, et al. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am J Med. 2002;112:89–94.
Saruta T, Omae T, Kuramochi M, et al. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control. J Hypertens. 1995;13(Suppl. 3):S23–S30.
Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1993;341:432.
Author information
Authors and Affiliations
Corresponding author
Additional information
To view enhanced content go to www.advancesintherapy.com
Rights and permissions
About this article
Cite this article
Shinohara, Y., Origasa, H. Post-Stroke Pneumonia Prevention by Angiotensin-Converting Enzyme Inhibitors: Results of a Meta-analysis of Five Studies in Asians. Adv Therapy 29, 900–912 (2012). https://doi.org/10.1007/s12325-012-0049-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-012-0049-1